Dr. Leland Gershell
Recent Articles about NuCana Plc.
Analyst's Target Price for Biotech Massively Higher Than Current Price 07/22/2024
Oppenheimer & Co. recently put out a report that gave NuCana Plc. (NCNA:NASDAQ) a target price of US$150. The stock is currently trading at US$2.98. Read on to see why the analyst has given the company such a massive target price.
© 2025 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
